Annual Report and Accounts for the year ended 30 June 2020

Dechra is a global specialist veterinary pharmaceuticals and related products business.

Our expertise is in the development, manufacture, marketing and sales of high quality products exclusively for veterinarians worldwide.

Our purpose is the sustainable improvement of animal health and welfare

Financial Performance

  • Revenue growth of 6.8% to £515.1 million.
  • Underlying operating profit increased to £128.3 million.
  • Underlying EBIT margin (excluding the impact of pension credit) reduced by 80 bps to 24.9% due to mix effect.
  • Underlying diluted EPS increased by 1.7% to 92.19 pence.
  • Reported operating profit growth of 33.3%.
  • Full year dividend increased by 8.5% to 34.29 pence.
  • Strong cash generation with cash conversion of 99.4%

Ampharmco integration progressing well, Mirataz acquisition completed in April 2020 and Osurnia completed in July 2020.

CAP performance robust.

FAP growth accelerating.

Numerous product registrations achieved, and significant progress made on Akston and Tri-Solfen.

We believe in the capability of our people and our ability to execute our strategy

Ian Page

Chief Executive Officer

Our existing business performed robustly this year, recovering well from first half supply issues and through the disruption caused by COVID-19

Paul Sandland

Chief Financial Officer

Our Purpose and Strategy


The sustainable improvement of animal health and welfare


Strategic Growth Drivers





Strategic Enablers

& Supply Chain





Our Values, entrepreneurial attitude and agile approach to the way we do things are the backbone of our Culture.
We expect our people to make a difference by collaborating with each other and we support them by providing clear guidance on expectations.

Our Strategy in Action

Corporate Social Responsibility

The Board takes ultimate responsibility for Corporate Social Responsibility (CSR) and is committed to developing and implementing appropriate policies that create and maintain long term value for shareholders. During the year, our newly formed CSR committee, made up of representatives from across the Group, reviewed the Group's CSR strategy along with the various frameworks for reporting, and published sustainability reports on Dechra, the latter identified reporting gaps where we could have provided more information on our activities.

Our Community

Our Business

Our People

Our Environment

Most material UN SDGs

Most material UN SDGs

Most material UN SDGs